Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes

被引:23
作者
Tittel, S. R. [1 ,2 ]
Sondern, K. M. [3 ]
Weyer, M. [4 ]
Poeplau, T. [5 ]
Sauer, B. M. [6 ]
Schebek, M. [7 ]
Ludwig, K-H [8 ]
Hammer, F. [9 ]
Froehlich-Reiterer, E. [10 ]
Holl, R. W. [1 ,2 ]
机构
[1] Ulm Univ, Inst Epidemiol & Med Biometry, Cent Inst Biomed Technol ZIBMT, Albert Einstein Allee 41, D-89081 Ulm, Germany
[2] German Ctr Diabet Res DZD, Munich, Germany
[3] Marien Hosp, Dortmund, Germany
[4] Kamillus Klin Internal Med, Asbach, Germany
[5] Ludgerus Kliniken GmbH, Clemenshosp, Munster, Germany
[6] Med Clin Internal Med, Spaichingen, Germany
[7] Paediat Clin, Kassel, Germany
[8] Paediat Clin Borromeans, Trier, Germany
[9] Cnopf Childrens Clin, Nurnberg, Germany
[10] Med Univ Graz, Dept Paediat, Graz, Austria
关键词
Hyperglycaemic hyperosmolar state; Diabetic ketoacidosis; Acute complication; Metabolic decompensation; Multicentre registry; CHILDREN; ADOLESCENTS; DIAGNOSIS; ADULTS; YOUTH; HYPOGLYCEMIA; ASSOCIATION; PREVENTION; THERAPY; GERMANY;
D O I
10.1007/s00592-020-01538-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To compare diabetes patients with hyperglycaemic hyperosmolar state (HHS), diabetic ketoacidosis (DKA), and patients without decompensation (ND). Methods In total, 500,973 patients with type 1 or type 2 diabetes of all ages registered in the diabetes patient follow-up (DPV) were included. Analysis was stratified by age (<= / > 20 years) and by manifestation/follow-up. Patients were categorized into three groups: HHS or DKA-during follow-up according to the most recent episode-or ND. Results At onset of diabetes, HHS criteria were met by 345 (68.4% T1D) and DKA by 9824 (97.6% T1D) patients. DKA patients had a lower BMI(-SDS) in both diabetes types compared to ND. HbA1c was higher in HHS/DKA. During follow-up, HHS occurred in 1451 (42.2% T1D) and DKA in 8389 patients (76.7% T1D). In paediatric T1D, HHS/DKA was associated with younger age, depression, and dyslipidemia. Pump usage was less frequent in DKA patients. In adult T1D/T2D subjects, metabolic control was worse in patients with HHS/DKA. HHS and DKA were also associated with excessive alcohol intake, dementia, stroke, chronic kidney disease, and depression. Conclusions HHS/DKA occurred mostly in T1D and younger patients. However, both also occurred in T2D, which is of great importance in the treatment of diabetes. Better education programmes are necessary to prevent decompensation and comorbidities.
引用
收藏
页码:1245 / 1253
页数:9
相关论文
共 42 条
[1]  
Al-Obaidi AH., 2019, Dubai Diabetes and Endocrinology Journal, V25, P52
[2]   Area Deprivation and Regional Disparities in Treatment and Outcome Quality of 29,284 Pediatric Patients With Type 1 Diabetes in Germany: A Cross-sectional Multicenter DPV Analysis [J].
Auzanneau, Marie ;
Lanzinger, Stefanie ;
Bohn, Barbara ;
Kroschwald, Peter ;
Kuhnle-Krahl, Ursula ;
Holterhus, Paul Martin ;
Placzek, Kerstin ;
Hamann, Johannes ;
Bachran, Rainer ;
Rosenbauer, Joachim ;
Maier, Werner .
DIABETES CARE, 2018, 41 (12) :2517-2525
[3]   Diabetic foot syndrome in patients with diabetes. A multicenter German/Austrian DPV analysis on 33870 patients [J].
Bohn, Barbara ;
Gruenerbel, Arthur ;
Altmeier, Marcus ;
Giesche, Carsten ;
Pfeifer, Martin ;
Wagner, Christian ;
Heise, Nikolai ;
Best, Frank ;
Fasching, Peter ;
Holl, Reinhard W. .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (06)
[4]  
Bradford Annabel L, 2017, J Clin Med Res, V9, P35
[5]  
Chiasson JL, 2003, CAN MED ASSOC J, V168, P859
[6]   Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center [J].
Fadini, Gian Paolo ;
de Kreutzenberg, Saula Vigili ;
Rigato, Mauro ;
Brocco, Stefano ;
Marchesan, Maria ;
Tiengo, Antonio ;
Avogaro, Angelo .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (02) :172-179
[7]   Comparison of Glycemic and Metabolic Control in Youth With Type 1 Diabetes With and Without Antipsychotic Medication: Analysis From the Nationwide German/Austrian Diabetes Survey (DPV) [J].
Galler, Angela ;
Bollow, Esther ;
Meusers, Michael ;
Bartus, Bela ;
Naeke, Andrea ;
Haberland, Holger ;
Schober, Edith ;
Holl, Reinhard W. .
DIABETES CARE, 2015, 38 (06) :1051-1057
[8]   The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments [J].
Garcia-Ropero, Alvaro ;
Badimon, Juan J. ;
Santos-Gallego, Carlos G. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (12) :1287-1302
[9]  
Giessmann HJ, 2018, ELGAR COMPANION TO POST-CONFLICT TRANSITION, P1
[10]   SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis [J].
Goldenberg, Ronald M. ;
Berard, Lori D. ;
Cheng, Alice Y. Y. ;
Gilbert, Jeremy D. ;
Verma, Subodh ;
Woo, Vincent C. ;
Yale, Jean-Francois .
CLINICAL THERAPEUTICS, 2016, 38 (12) :2654-2664